Testing effectiveness (Phase 2)Study completedNCT00634751
What this trial is testing
CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
Who this might be right for
Pancreatic NeoplasmsBile Duct Neoplasms
University of Wisconsin, Madison 48